DOTmed September 1, 2024
Furthermore, Bot Image, Inc. announces verification of a CPT payment code for its 3D Reconstruction of Prostate Tumors detected using bpMRI.
Bot Image, Inc., a Nebraska and Maine based Artificial Intelligence medical device company, (botimage.ai.com) demonstrated through partnerships in the radiology and urology communities that its novel 3D prostate tumor modeling of detected lesions is reimbursable by Medicare and United Healthcare. These 3D outputs can greatly assist Oncologists in treatment planning and targeting.
Bot Image’s artificial intelligence software, ProstatID®, received FDA clearance June 23, 2022 for its software outputs generated from interpretation of prostate MRIs. From the 510(k) Summary: Output of the device includes the {3D} volume of the prostate and locations, as well as the extent of suspect lesions,...
Today's Sponsors
Today's Sponsor